Sep 18, 2020 - Drugs & Medical Devices by Justin Roberts
A popular weight-loss drug has been linked to cancer. Specifically, the FDA requested the withdrawal of Belviq (otherwise known by its generic name of lorcaserin hydrochloride) from the market after determining the drug's potential risks outweigh its benefits. Now, patients who have developed...